Rayleigh Optoelectronics

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Rayleigh Optoelectronics - overview

Established

2023

Location

Zhuhai, Guangdong, China

Primary Industry

Medical Devices & Equipment

About

Based in Zhuhai, China and founded in 2023, SCNU Rayleigh Optoelectronics Technology (Zhuhai) Co. , Ltd. , trading as Rayleigh Optoelectronics, is a high-tech enterprise engaged in the research, development, production, and sales of high-end FRET (Fluorescence Resonance Energy Transfer) microscopy imaging systems and the provision of scientific research and testing services. The company was founded by Zhengfei Zhuang and Tongsheng Chen, two professors at South China Normal University (SCNU).


The company has obtained more than 30 independent intellectual property rights and has established partnerships with Tsinghua University, Shanghai Jiao Tong University and Sun Yat-sen University Cancer Hospital. In January 2024, Rayleigh Optoelectronics closed angel funding led by returning investor Zhuhai Zhengling Capital, with participation from new investor Leadway Capital. Rayleigh Optoelectronics' main offerings include living cell microscopy imaging analyzers such as living cell intelligent quantitative FRET microscopy analyzer, fast dual-channel FRET fully automatic imaging analyzer, multimodal FRET fully automatic imaging analyzer, and related supporting LED light sources. The company also develops low-through airtightness testing equipment and offers services such as FRET testing services and fluorescence microscope upgrade and modification (by adding FRET detection and analysis module).


The company generates revenue by providing the optical instrument manufacturing and sales, cell technology R&D and application, and intelligent instrumentation manufacturing. The company will use the angel funding for team building, product iteration, and business development, driving the transformation, industrialization, and commercialization of technological achievements.


Current Investors

Zhuhai Zhengling Venture Capital, Leadway Capital, Zhuhai Zhengling Capital

Primary Industry

Medical Devices & Equipment

Sub Industries

Optometrists & Opticians Products and Services, Diagnostic Equipment

Website

www.rayleigh.com.cn

Verticals

HealthTech, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.